Congenital parvovirus syndrome (Q45753): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: P35 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:57, 13 August 2026
Fetal parvovirus syndrome is a fetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Fetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and fetal death by cardiac failure in 10 to 20% of cases.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KA62.7 |
||
| English | Congenital parvovirus syndrome |
Fetal parvovirus syndrome is a fetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Fetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and fetal death by cardiac failure in 10 to 20% of cases. |
Statements
CID11:KA62.7
0 references
dki-india-KA62.7
0 references
Concluído
0 references
13 August 2026
0 references
